Editor's note: Some of the sources for this article requested their full names and locations not be used.
Cervical cancer is the third most common cancer globally, most often caused by several high-risk strains of the human papillomavirus (HPV). To combat this, women older than age 21 in the United States and age 25 in the United Kingdom are encouraged to have regular cervical screening tests to identify whether they have contracted HPV and to make sure it's found as early as possible.
However, transgender men and nonbinary people with cervixes, who are at equal if not higher risk of cervical cancer than cisgender women, are often left out of the equation.
Research indicates transgender men are significantly less likely to be up to date with cervical screenings compared to cisgender women. In the U.K., a small-scale 2021 study found only 58 percent of trans participants eligible for a cervical screening actually had been screened, and just 53 percent felt they had sufficient information about cervical screening.